Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.13 - $12.25 $1.83 Million - $7.14 Million
-583,206 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$9.54 - $14.26 $795,597 - $1.19 Million
-83,396 Reduced 12.51%
583,206 $6.59 Million
Q4 2021

Feb 14, 2022

BUY
$7.34 - $10.25 $2.03 Million - $2.84 Million
276,790 Added 71.01%
666,602 $6.38 Million
Q3 2021

Nov 15, 2021

BUY
$8.05 - $13.29 $3.14 Million - $5.18 Million
389,812 New
389,812 $3.45 Million
Q3 2020

Nov 12, 2020

SELL
$11.74 - $22.0 $1.17 Million - $2.2 Million
-100,000 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$5.67 - $15.86 $567,000 - $1.59 Million
100,000 New
100,000 $1.21 Million

Others Institutions Holding IMUX

About IMMUNIC, INC.


  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $30.6M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.